Sumary of Pediatric patients with IBD may face higher cancer, mortality risks:
- October 20, 2021 2 min read Source/Disclosures Published by: Source: Dupont-Lucas C, et al.
- Although cancer and mortality are dreaded complications of IBD, they’re rarely observed during the pediatric follow-up of the disease.
- Hence, the risk for cancer and mortality in pediatric-onset IBD are poorly known.
- ” To investigate the prevalence of cancer and mortality in patients with pediatric-onset IBD and to identify the factors associated with cancer and mortality, researchers used the EPIMAD registry to assess data from pediatric patients diagnosed with IBD before age 17 years from 1988 to 2011. Incident cancer data were collected through Dec.
- Researchers recorded 14 cases of cancer (median delay after IBD diagnosis, 15 years;
- median age at cancer diagnosis, 27.8 years) across the cohort;
- There was a significantly higher incidence of cancer compared with the general population (standardized cancer incidence ratio [SIR] = 2.66;
- 95% CI, 17.55-98.98), followed by skin cancer (basal cell carcinoma and melanoma), were the leading causes of death, according to Dupont-Lucas.